Aurobindo again under FDA fire; Bureaucrats still trying to define "counterfeit;"

> The FDA wants a detailed action plan from Aurobindo Pharma for packaging and labeling compliance at its facility near Hyderabad in southern India. Story

> The World Health Assembly has decided it needs another year before it can make recommendations to fight drug counterfeiting; still problematic is the untangling of trade and intellectual property issues from counterfeiting. Article

> Pfizer says it will spend $21 million to upgrade sterile manufacturing ops at its Portage, MI, facility. Report

> Contract drug developer and manufacturer The Almac Group last week opened its new North American headquarters in Souderton, PA. Release

> Texas A&M University has stepped forward to become one of the U.S. centers for defense against infectious diseases and other biological threats. Item

> AstraZeneca says it's cutting 145 manufacturing jobs at its Westborough, MA, plant. Story

> India plans to announce details about whether the makers of patented drugs are meeting domestic demand at reasonable prices. News

> Nigeria has mandated that patent medicine dealers establish self-regulatory mechanisms for adherence to ethical standards. Article

Suggested Articles

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot. 

The FDA recently asked five drug manufacturers to recall the commonly used diabetes med metformin. With COVID-19 raging, is metformin just the start?

The antidepressant Zoloft and its generics are in short supply as the COVID-19 pandemic has caused higher demand and manufacturing interruptions.